Renasant

RNSTNYSEUSD

THESIS ALERT

Email me when the RNST thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$40.25
+$0.06 (+0.15%)Today 1M +3.02%
After hours$40.250.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$40.19
Prior regular-session close from the quote source.
$39.77–$40.31
Regular-session low and high so far today.
627.7K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$33.16–$44.54
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own RNST if it preserves margins and controls credit costs, scale should convert into durable earnings and cash return to shareholders.

RNST price history

Latest price$40.25Today+$0.06 (+0.15%)
RNST +2.03%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Large balance-sheet expansion (acquisitions or deposit/loan growth) is the primary driver of revenue growth; if that expansion is sustained and the assets perform, revenue will remain elevated.StrengtheningMateriality: High

    Assets increased from $18,034,868,000 (period_end 2024) to $26,751,426,000 (period_end 2025), indicating major balance-sheet expansion. If asset growth is profitable, top-line expansion funds higher earnings and cash returns; if not, revenue can rise while economic returns decline.

    Watch: Acquisition or loan portfolio credit deterioration in the acquired book (rising NPLs or charge-offs) that reduces earning power of new assets.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Assets increased from $18,034,868,000 (period_end 2024) to $26,751,426,000 (period_end 2025), indicating major balance-sheet expansion.

    Open source ↗
  • Conversion of higher revenue into sustained net income depends on preserving net interest margin and limiting credit provisions; revenue alone won’t ensure earnings durability.HoldingMateriality: High

    Net income declined from $195,457,000 (2024) to $181,272,000 (2025) even as revenue jumped, implying margin/credit/expense pressures during expansion. If margin compression or higher provisions offset revenue gains, EPS and cash returns will lag despite larger assets.

    Watch: Sustained deterioration in loan performance in newly acquired portfolios that forces rising provisions and credit costs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Net income declined from $195,457,000 (2024) to $181,272,000 (2025) even as revenue jumped, implying margin/credit/expense pressures during expansion.

    Open source ↗
  • Per-share earnings recovery hinges on the capital mix (equity vs. cash) used to fund growth: if growth is financed with stable capital and/or buybacks, EPS should rebound; if financed with share issuance or persistent goodwill, EPS will remain pressured.HoldingMateriality: Medium

    EPS diluted fell from $3.27 (2024) to $2.07 (2025) while assets and equity increased, suggesting financing/integration effects impacted per-share results. EPS drives market valuation; dilution or capital-consuming deals prevent shareholders from benefiting even if the balance sheet grows.

    Watch: Management-funded acquisitions through significant share issuance or large goodwill that reduces future ROE and prevents buybacks.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    EPS diluted fell from $3.27 (2024) to $2.07 (2025) while assets and equity increased, suggesting financing/integration effects impacted per-share results.

    Open source ↗
  • Renasant’s larger equity base provides regulatory and economic capital to pursue further loan growth and M&A; if capital cushions hold, the company can continue scaling without immediate solvency pressure.StrengtheningMateriality: Medium

    Stockholders' equity increased to $3,884,905,000 at 2025-12-31 from $2,678,318,000 at 2024-12-31, expanding the capital base available for growth. Adequate capital gives flexibility for accretive deals and protects against cyclical credit losses; insufficient capital would force deleveraging or expensive capital raises.

    Watch: Regulatory capital requirement changes or higher risk-weighting of acquired assets that consume capital faster than earnings replenish it.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Stockholders' equity increased to $3,884,905,000 at 2025-12-31 from $2,678,318,000 at 2024-12-31, expanding the capital base available for growth.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Large balance-sheet expansion (acquisitions or deposit/loan growth) is the primary driver of revenue growth; if that expansion is sustained and the assets perform, revenue will remain elevated. If asset growth is profitable, top-line expansion funds higher earnings and cash returns; if not, revenue can rise while economic returns decline.

Conversion of higher revenue into sustained net income depends on preserving net interest margin and limiting credit provisions; revenue alone won’t ensure earnings durability. If margin compression or higher provisions offset revenue gains, EPS and cash returns will lag despite larger assets.

Per-share earnings recovery hinges on the capital mix (equity vs. cash) used to fund growth: if growth is financed with stable capital and/or buybacks, EPS should rebound; if financed with share issuance or persistent goodwill, EPS will remain pressured. EPS drives market valuation; dilution or capital-consuming deals prevent shareholders from benefiting even if the balance sheet grows.

Renasant’s larger equity base provides regulatory and economic capital to pursue further loan growth and M&A; if capital cushions hold, the company can continue scaling without immediate solvency pressure. Adequate capital gives flexibility for accretive deals and protects against cyclical credit losses; insufficient capital would force deleveraging or expensive capital raises.

All standing thesis claims
Original report summary

it preserves margins and controls credit costs, scale should convert into durable earnings and cash return to shareholders.

Evidence assessed Nov 9, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Renasant

Where the evidence on Renasant stands: Holding on the latest evidence (Nov 9, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.

Bull case: what the evidence supports

  • Large balance-sheet expansion (acquisitions or deposit/loan growth) is the primary driver of revenue growth; if that expansion is sustained and the assets perform, revenue will remain elevated.

    sec.gov ↗

  • Conversion of higher revenue into sustained net income depends on preserving net interest margin and limiting credit provisions; revenue alone won’t ensure earnings durability.

    sec.gov ↗

  • Per-share earnings recovery hinges on the capital mix (equity vs. cash) used to fund growth: if growth is financed with stable capital and/or buybacks, EPS should rebound; if financed with share issuance or persistent goodwill, EPS will remain pressured.

    sec.gov ↗

  • Renasant’s larger equity base provides regulatory and economic capital to pursue further loan growth and M&A; if capital cushions hold, the company can continue scaling without immediate solvency pressure.

    sec.gov ↗

Bear case: what would count against it

  • Acquisition or loan portfolio credit deterioration in the acquired book (rising NPLs or charge-offs) that reduces earning power of new assets.

    sec.gov ↗

  • Sustained deterioration in loan performance in newly acquired portfolios that forces rising provisions and credit costs.

    sec.gov ↗

  • Management-funded acquisitions through significant share issuance or large goodwill that reduces future ROE and prevents buybacks.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Renasant

Loading the break-condition record for Renasant.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Entered a material definitive agreement.

    Renasant filed an SEC 8-K on 2026-10-27: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Renasant filed an SEC 8-K on 2026-10-27: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Director or principal officer change.

    Renasant filed an SEC 8-K on 2026-08-25: Director or principal officer change. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Acquisition or loan portfolio credit deterioration in the acquired book (rising NPLs or charge-offs) that reduces earning power of new assets.
  • Sustained deterioration in loan performance in newly acquired portfolios that forces rising provisions and credit costs.
  • Management-funded acquisitions through significant share issuance or large goodwill that reduces future ROE and prevents buybacks.
  • Regulatory capital requirement changes or higher risk-weighting of acquired assets that consume capital faster than earnings replenish it.

RNST news

Loading headlines…

Financial statements

RNST income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

RNST: quick answers

Have members of Congress traded RNST?
Reports made public in the last 90 days disclose 1 trade in RNST by 1 filer: 0 purchases and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed RNST trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.